Here's an update current to close of business today. All holdings as reported in March quarterly.
![]()
We have an enterprise value of minus $2.9M excluding the value of projects shell and management expertise.
If we assume the shell plus projects is worth around $5m (more or less), then management must be worth around minus $7.9m or minus 9.5 cents per share. If this "anomaly" were removed we should see an immediate gain of 73%. (ie: $0.13 plus $0.095 = $0.225)
- Forums
- ASX - By Stock
- E25
- Montezuma update and potential
Montezuma update and potential, page-7
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add E25 (ASX) to my watchlist
|
|||||
Last
25.0¢ |
Change
0.015(6.38%) |
Mkt cap ! $51.67M |
Open | High | Low | Value | Volume |
25.0¢ | 25.0¢ | 25.0¢ | $325 | 1.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 32916 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 1956 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1300 | 0.250 |
1 | 24468 | 0.235 |
2 | 41387 | 0.215 |
6 | 276670 | 0.210 |
2 | 35000 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 1957 | 2 |
0.260 | 19607 | 1 |
0.265 | 21010 | 2 |
0.270 | 20000 | 1 |
0.275 | 97981 | 3 |
Last trade - 10.02am 16/07/2024 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online